EGFR and non-small cell lung carcinoma: From December 2017 through July 2020, a total of 108 effusion samples from 78 patients with advanced NSCLC were prospectively collected and EGFR mutation testing was performed within three months after collection (median, 8.5 days; range, 0 – 91 days).